Suppr超能文献

p16(INK4a)免疫细胞化学在接受高级别鳞状上皮内病变治疗的女性液基细胞学标本中的应用。

Utility of p16(ink4a) immunocytochemistry in liquid-based cytology specimens from women treated for high-grade squamous intraepithelial lesions.

作者信息

Carydis Vasiliki Bessie, Walker Todd, Wing Anthony, Colgan Terence J

机构信息

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.

出版信息

Acta Cytol. 2007 Jul-Aug;51(4):517-22. doi: 10.1159/000325787.

Abstract

OBJECTIVE

To examine whether p16(ink4a) immunocytochemical (ICC) expression detected intraepithelial disease in liquid-based cytology (LBC) specimens from women with high-grade squamous intraepithelial lesions (HSIL), whose specimen was labeled negative for intraepithelial lesion or malignany (NILM).

STUDY DESIGN

Residual LBC specimens from women treated for HSIL (n = 21), whose LBC test was interpreted as NILM including marked benign inflammatory changes (BCC) were used. The control (n = 25) consisted of residual LBC specimens from women with documented HSIL. ICC for p16p(16k4a) was performed on a second ThinPrep (ThinPrep 2000, Cylyl Corporation, Boxborough, Massachusetts, U.S.A.) preparation; the percentage ofpositive cells and intensity of immunostaining were recorded. Standard LBC preparations for p16(ink4a) ICC-positive and ICC-negative control cases were reviewed.

RESULTS

Twenty-four of 25 (96%) of the HSIL control group were ICC p16(ink4a) positive. In the NILM/BCC group, 2 of 21 with adequate LBC residua were ICC p16(ink4a) positive; on review both were reclassified as epithelial abnormality--1 HSIL and 1 atypical squamous cells cannot exclude HSIL. In both, subsequent colposcopic biopsy yielded HSIL.

CONCLUSION

p16(ink4a) ICC positivity on NILM/BCC LBC residua from patients with HSIL may identify cases that merit cytologic review and possible reclassification. The utility of p16(ink4a) ICC in this situation requires further study.

摘要

目的

探讨在高级别鳞状上皮内病变(HSIL)女性的液基细胞学(LBC)标本中,p16(ink4a)免疫细胞化学(ICC)表达能否检测出上皮内病变,这些女性的标本上皮内病变或恶性肿瘤标记为阴性(NILM)。

研究设计

使用接受HSIL治疗的女性(n = 21)的剩余LBC标本,其LBC检测结果为NILM,包括明显的良性炎症改变(BCC)。对照组(n = 25)由记录有HSIL的女性的剩余LBC标本组成。在第二个ThinPrep(ThinPrep 2000,Cylyl公司,美国马萨诸塞州博克斯伯勒)制备物上进行p16p(16k4a)的ICC检测;记录阳性细胞百分比和免疫染色强度。对p16(ink4a)ICC阳性和ICC阴性对照病例的标准LBC制备物进行复查。

结果

HSIL对照组25例中有24例(96%)ICC p16(ink4a)呈阳性。在NILM/BCC组中,21例有足够LBC剩余标本的患者中有2例ICC p16(ink4a)呈阳性;复查后两者均重新分类为上皮异常——1例HSIL和1例非典型鳞状细胞不能排除HSIL。两者随后的阴道镜活检均为HSIL。

结论

HSIL患者NILM/BCC LBC剩余标本中p16(ink4a)ICC阳性可能识别出值得进行细胞学复查和可能重新分类的病例。在这种情况下p16(ink4a)ICC的效用需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验